Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Gilks

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Nature|May 10, 2002
HIV in Africa (Communication arising): chemokine-receptor genes and AIDS riskPatricia A Ramaley, Neil French, Pontiano Kaleebu, et al.
AIDS Care|July 20, 2018
Addressing smoking among people living with HIV: a cross-sectional survey of Australian HIV health practitioners' practices and attitudesStephanie K Bell, Gabriela Mena, Judith Dean, et al.
Sexually Transmitted Infections|September 30, 2010
Changes in antiretroviral therapy guidelines: implications for public health policy and public pursesAlex Hamilton, Jesus M Garcia-Calleja, Marco Vitoria, et al.
AIDS Care|August 5, 2024
Perceptions of nicotine vaping products among Australians living with HIVStephanie Edwards, Cheneal Puljević, Judith A Dean, et al.
Australian Journal of Primary Health|October 16, 2023
Reducing antibiotic prescribing in general practice in Australia: a cluster randomised controlled trial of a multimodal interventionMinyon L Avent, Lisa Hall, Mieke van Driel, et al.
AIDS Research and Treatment|April 15, 2011
CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI SubstudyJennifer Serwanga, Susan Mugaba, Auma Betty, et al.
International Journal of Environmental Research and Public Health|July 19, 2017
Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who SmokeStephanie Bell, Judith Dean, Charles Gilks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic SettingsDavid Dunn, Huw Price, Tobias Vudriko, et al.
The International Journal on Drug Policy|July 2, 2017
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: Findings from the Queensland Injectors' Health NetworkLeith Morris, Andrew Smirnov, Amanda Kvassay, et al.
Sexually Transmitted Infections|April 19, 2012
Knowing your HIV/AIDS epidemic and tailoring an effective response: how did India do it?Sema K Sgaier, Mariam Claeson, Charles Gilks, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Nature|May 10, 2002
HIV in Africa (Communication arising): chemokine-receptor genes and AIDS riskPatricia A Ramaley, Neil French, Pontiano Kaleebu, et al.
AIDS Care|July 20, 2018
Addressing smoking among people living with HIV: a cross-sectional survey of Australian HIV health practitioners' practices and attitudesStephanie K Bell, Gabriela Mena, Judith Dean, et al.
Sexually Transmitted Infections|September 30, 2010
Changes in antiretroviral therapy guidelines: implications for public health policy and public pursesAlex Hamilton, Jesus M Garcia-Calleja, Marco Vitoria, et al.
AIDS Care|August 5, 2024
Perceptions of nicotine vaping products among Australians living with HIVStephanie Edwards, Cheneal Puljević, Judith A Dean, et al.
Australian Journal of Primary Health|October 16, 2023
Reducing antibiotic prescribing in general practice in Australia: a cluster randomised controlled trial of a multimodal interventionMinyon L Avent, Lisa Hall, Mieke van Driel, et al.
AIDS Research and Treatment|April 15, 2011
CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI SubstudyJennifer Serwanga, Susan Mugaba, Auma Betty, et al.
International Journal of Environmental Research and Public Health|July 19, 2017
Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who SmokeStephanie Bell, Judith Dean, Charles Gilks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2020
New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic SettingsDavid Dunn, Huw Price, Tobias Vudriko, et al.
The International Journal on Drug Policy|July 2, 2017
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: Findings from the Queensland Injectors' Health NetworkLeith Morris, Andrew Smirnov, Amanda Kvassay, et al.
Sexually Transmitted Infections|April 19, 2012
Knowing your HIV/AIDS epidemic and tailoring an effective response: how did India do it?Sema K Sgaier, Mariam Claeson, Charles Gilks, et al.
Pageof 4